Skip to Main Content
Social Media Directory
PROGRAMS & RESOURCES
PDMP Use Mandate Information
PDMP Updates and Reports
Health Care Providers and Delegates
PDMP Investigative Users
PDMP Advisory Board
PDMP Law and Regulations
Prescription Drug Abuse
PDMP Registration FAQs
PDMP Mandated Use FAQs
OCSA Continuing Education Requirement
Maryland Prescription Drug Monitoring Program
for updates on the Dispenser migration from RxSentry to RxGov, beginning April 2019.
HEALTHCARE PROVIDER REGISTRATION: Please click on the PDMP logo button below for access to the CRISP Registration Page
Advisory Board Vacancy
Section 21–2A–05 of the Health-General Article provides for the creation of the Advisory Board on Prescription Drug Monitoring Program (
PDMP Advisory Board
). On behalf of the Secretary of the Maryland Department of Health, the Office of Provider Engagement and Regulation (OPER) is requesting nominations to fill the current vacancy of a Patient Representative to the Advisory Board. Please select the link below to begin the application process. The deadline to apply is October 23, 2020.
Maryland Department of Health – Board Application
FAQ’s – PDMP Advisory Board
PRESCRIPTION DRUG MONITORING PROGRAM (PDMP)
The Prescription Drug Monitoring Program (PDMP) has been established by the Maryland Department of Health,
to support healthcare providers and their patients in the safe and effective use of prescription drugs. The PDMP collects and securely stores information on drugs that contain controlled substances and are dispensed to patients in Maryland. Drug dispensers, including pharmacies and healthcare practitioners, electronically report the information that is stored in the PDMP database.
Access to prescription data is made available at no-cost to physicians, nurse practitioners, pharmacists and others that provide pharmaceutical care to their patients.
By law, healthcare providers may only access information on patients under their care. Use of prescription information improves providers’ ability to manage the benefits and risks of controlled substance medications and identify potentially harmful drug interactions.
The PDMP also assists agencies responsible for ensuring public health and safety through the investigation of illegal or inappropriate prescribing, dispensing or use of prescription drugs. Investigators must register with the PDMP and may only request data to support an existing investigation, typically supported by a subpoena for the information.
Lastly, the PDMP supports research and educational initiatives designed to broaden public understanding of prescription drug abuse and develop more effective approaches to addressing this serious personal and public health challenge.
The PDMP is a core component of the State’s and many local jurisdictions’ strategies for reducing alcohol- and drug-related overdoses.
For general information about the PDMP, see the
Frequently Asked Questions
section.For information about clinical user access to PDMP data, please view the
PDMP Training Video
.If you have additional questions, please
contact the PDMP
201 W. Preston Street, Baltimore, MD 21201-2399
(410) 767-6500 or 1-877-463-3464
MD Social Media Directory